Global Life Sciences BPO Market 2014-2018

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.1.1 Contract Manufacturing Organizations
06.1.2 Contract Research Organizations
06.1.3 Contract Sales Organizations
06.2 Market Size and Forecast
06.3 Market Segmentation
06.4 Contract Manufacturing Organizations
06.5 Contract Research Organizations
06.6 Contract Sales Organizations
06.7 Five Forces Analysis
07. Geographical Segmentation
07.1 Global Life Sciences BPO Market by Geographical Segmentation 2013
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors
15.3.1 Ashfield Healthcare
15.3.2 Charle River Laboratories
15.3.3 DSM
15.3.4 Icon plc
15.3.5 INC Research
15.3.6 inVentive Health
15.3.7 Parexel International Corp.
15.3.8 PDI Inc.
15.3.9 Piramal Enterprises
15.3.10 Quintiles Translational Corp.
15.3.11 Ricerca Biosciences LLC
15.3.12 Siro Clinpharm
15.3.13 Takeda Pharmaceutical Co. Ltd.
15.3.14 Vanguard Pharma
15.3.15 Wipro
15.3.16 WuXi App Tec.
16. Key Vendor Analysis
16.1 Catalent
16.1.1 Key Facts
16.1.2 Business Overview
16.1.3 Business Segmentation by Revenue 2014
16.1.4 Business Segmentation by Revenue 2013 and 2014
16.1.5 Geographical Segmentation by Revenue 2014
16.1.6 Business Strategy
16.1.7 Recent Developments
16.1.8 SWOT Analysis
16.2 Cognizant
16.2.1 Key Facts
16.2.2 Business Overview
16.2.3 Business Segmentation by Revenue 2013
16.2.4 Business Segmentation by Revenue 2012 and 2013
16.2.5 Geographical Segmentation by Revenue 2013
16.2.6 Business Strategy
16.2.7 Key Information
16.2.8 SWOT Analysis
16.3 Covance
16.3.1 Key Facts
16.3.2 Business Overview
16.3.3 Business Segmentation by Revenue 2013
16.3.4 Business Segmentation by Revenue 2012 and 2013
16.3.5 Geographical Segmentation by Revenue 2013
16.3.6 Business Strategy
16.3.7 Recent Developments
16.3.8 SWOT Analysis
16.4 PRA Health Sciences
16.4.1 Key Facts
16.4.2 Business Overview
16.4.3 Product Segmentation
16.4.4 Geographical Segmentation
16.4.5 Business Strategy
16.4.6 Recent Developments
16.4.7 SWOT Analysis
17. Other Reports in this Series